View Cart
My AccountInfectious Disease Diagnostic Solutions
Microbix Phone+1803294983432Microbix Emailcustomer.service@microbix.com
Microbix Logo
Request Catalogue Contact Us
  • Services
    • Assay Development Solutions
    • Custom Vial Filling Services
  • Products
    • Reference Materials (QUANTDx™)
    • Antigens
      • All Antigens
      • Childhood Disease Antigens
      • Dengue Antigens
      • STI Antigens
      • ToRCH Antigens
      • Respiratory Antigens
      • Other Antigens
    • External Quality Controls (QAPs™)
      • All External QC Products
      • Respiratory Viral Panel
      • STI Panel
      • HPV Panel
      • Gastrointestinal Panel
      • Genital Ulcer Panel
      • Vaginal Infections Panel
      • ONBOARDx Kits
      • Proficiency Testing Panel
      • Technical Resources
    • DxTM™ Viral Transport Medium
    • Control Elution Buffer
    • Kinlytic (Urokinase)
  • About
    • Who We Are
    • Who We Work With
    • Quality
    • Board of Directors
    • Our Senior Team
    • Careers
  • Resources
    • White Papers
    • Poster Publication
    • Podcasts
  • Investors
    • News Releases
    • Financial Reports
    • Corporate Presentations
    • Analyst Coverage
    • Corporate Governance
    • Stock Information
Contact Us
Microbix Further Optimizes Capital Usage and Availability

Microbix Further Optimizes Capital Usage and Availability

by Shitika Kulshreshtha | Mar 26, 2025 | Blog, Media Features News Releases, News Releases

Debt Repayment & Credit Expansion Provides Savings & Maintains Resilience   MISSISSAUGA, CANADA, March 26, 2025 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces the further...
Microbix & ACPCC support efforts to eliminate cervical cancer in the Indo-Pacific

Microbix & ACPCC support efforts to eliminate cervical cancer in the Indo-Pacific

by Shitika Kulshreshtha | Mar 17, 2025 | Blog, Media Features News Releases, News Releases

EPICC HPV Elimination Partnership being supplied PROCEEDxFLOQ QAPs to Support Test Accuracy   MISSISSAUGA, ONTARIO, CANADA & MELBOURNE, VICTORIA, AUSTRALIA, March 17 2025 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences...
Microbix Hosts Ontario Premier Doug Ford & Team

Microbix Hosts Ontario Premier Doug Ford & Team

by Shitika Kulshreshtha | Feb 27, 2025 | Blog, Media Features News Releases, News Releases

Site Visit & Discussions with Premier Ford & MPP Deepak Anand   MISSISSAUGA, CANADA, February 27, 2025 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a proudly Ontario Made life sciences innovator, manufacturer, and exporter, was...
Microbix Announces Issuance of Stock Options

Microbix Announces Issuance of Stock Options

by Shitika Kulshreshtha | Feb 26, 2025 | Blog, Media Features News Releases, News Releases

Using Shareholder-Approved Plan to Incentivize and Retain   MISSISSAUGA, CANADA, February 26, 2025 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces the issuance of stock options...
Microbix’s Virtual AGM 2025

Microbix’s Virtual AGM 2025

by Shitika Kulshreshtha | Feb 21, 2025 | Events, Media Featured Upcoming Events

Microbix will be hosting a virtual AGM on March 26, 2025, at 1:00 pm.   The online link will allow shareholders to listen to the AGM and view a CEO presentation via Zoom. Shareholders without up-to-date computer access can listen-in via telephone by using the...
« Older Entries
Next Entries »
  • Investors
  • Legal
  • Contact
  • News Releases
  • Accessibility
  • Careers
Microbix Funded By